Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
Bidard, Francois-Clement, Kaklamani, Virginia G, Neven, Patrick, Streich, Guillermo, Montero, Alberto J, Forget, Frédéric, Mouret-Reynier, Marie-Ange, Sohn, Joo Hyuk, Taylor, Donatienne, Harnden, Kathleen K, Khong, Hung, Kocsis, Judit, Dalenc, Florence, Dillon, Patrick M, Babu, Sunil, Waters, Simon, Deleu, Ines, García Sáenz, José A, Bria, Emilio, Cazzaniga, Marina, Lu, Janice, Aftimos, Philippe, Cortés, Javier, Liu, Shubin, Tonini, Giulia, Laurent, Dirk, Habboubi, Nassir, Conlan, Maureen G, Bardia, Aditya
Published in Journal of clinical oncology (01.10.2022)
Published in Journal of clinical oncology (01.10.2022)
Get full text
Journal Article
Higher relative survival in breast cancer patients treated in certified and high-volume breast cancer centres – A population-based study in Belgium
Leroy, Roos, Silversmit, Geert, Bourgeois, Jolyce, De Gendt, Cindy, Savoye, Isabelle, Verbeeck, Julie, Van Damme, Nancy, Stordeur, Sabine, Canon, Jean-Luc, Carly, Birgit, Cusumano, Pino G., de Azambuja, Evandro, De Visschere, Pieter, Decloedt, Jan, Desreux, Joëlle, Duhoux, Francois P., Taylor, Donatienne, van Dam, Peter, Vanhoutte, Ilse, Veldeman, Liv, Wildiers, Hans
Published in European journal of cancer (1990) (01.10.2024)
Published in European journal of cancer (1990) (01.10.2024)
Get full text
Journal Article
Oral elacestrant vs standard-of-care in estrogen receptor-positive, HER2-negative (ER+/HER2-) advanced or metastatic breast cancer (mBC) without detectable ESR1 mutation (EMERALD): Subgroup analysis by prior duration of CDK4/6i plus endocrine therapy (ET)
Kaklamani, Virginia G., Bidard, Francois Clement, Neven, Patrick, Montero, Alberto J., Mouret-Reynier, Marie-Ange, Sohn, Joohyuk, Taylor, Donatienne, Forget, Frederic, Harnden, Kathleen Kiernan, Khong, Hung T., Kocsis, Judit, Dalenc, Florence, Dillon, Patrick Michael, Waters, Simon, García-Sáenz, José A., Aftimos, Philippe Georges, Cortes, Javier, Scartoni, Simona, Habboubi, Nassir, Bardia, Aditya
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab
Debien, Veronique, Marta, Guilherme Nader, Agostinetto, Elisa, Sirico, Marianna, Jacobs, Flavia, Molinelli, Chiara, Moreau, Michel, Paesmans, Marianne, De Giorgi, Ugo, Santoro, Armando, Taylor, Donatienne, Duhoux, François P., Botticelli, Andrea, Barchiesi, Giacomo, Speranza, Iolanda, Lambertini, Matteo, Wildiers, Hans, Azambuja, Evandro de, Piccart, Martine
Published in Critical reviews in oncology/hematology (01.10.2023)
Published in Critical reviews in oncology/hematology (01.10.2023)
Get full text
Journal Article
Subgroup analysis of patients with no prior chemotherapy in EMERALD: A phase 3 trial evaluating elacestrant, an oral selective estrogen receptor degrader (SERD), versus investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/metastatic breast cancer (mBC)
Kaklamani, Virginia G., Bardia, Aditya, Aftimos, Philippe Georges, Cortes, Javier, Lu, Janice M., Neven, Patrick, Streich, Guillermo, Montero, Alberto J., Forget, Frederic, Mouret-Reynier, Marie-Ange, Sohn, Joohyuk, Taylor, Donatienne, Harnden, Kathleen Kiernan, Khong, Hung T., Kocsis, Judit, Dalenc, Florence, Dillon, Patrick Michael, Tonini, Giulia, Grzegorzewski, Kris, Bidard, François-Clement
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Abstract OT1-18-02: First-line chemo-immunotherapy with durvalumab, paclitaxel and carboplatin with or without anti-CD73 antibody oleclumab in advanced or metastatic triple-negative breast cancer: Preliminary results of the randomized phase II SYNERGY trial
Debien, Veronique, Maurer, Christian, Aftimos, Philippe, Clatot, Florian, Loirat, Delphine, Punie, Kevin, Ghiringhelli, François, Gonçalves, Anhony, Taylor, Donatienne, Van den Mooter, Tom, Ferrero, Jean-Marc, Bonnefoi, Hervé, Canon, Jean-Luc, Duhoux, François, Poncin, Renaud, Bazan, Fernando, Isambert, Nicolas, Barthelemy, Philippe, Brandão, Mariana, Kristanto, Paulus, Ignatiadis, Michail, Piccart, Martine, Buisseret, Laurence
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial
Buisseret, Laurence, Loirat, Delphine, Aftimos, Philippe, Maurer, Christian, Punie, Kevin, Debien, Véronique, Kristanto, Paulus, Eiger, Daniel, Goncalves, Anthony, Ghiringhelli, François, Taylor, Donatienne, Clatot, Florent, Van den Mooter, Tom, Ferrero, Jean-Marc, Bonnefoi, Hervé, Canon, Jean-Luc, Duhoux, Francois P., Mansi, Laura, Poncin, Renaud, Barthélémy, Philippe, Isambert, Nicolas, Denis, Zoë, Catteau, Xavier, Salgado, Roberto, Agostinetto, Elisa, de Azambuja, Evandro, Rothé, Françoise, Craciun, Ligia, Venet, David, Romano, Emanuela, Stagg, John, Paesmans, Marianne, Larsimont, Denis, Sotiriou, Christos, Ignatiadis, Michail, Piccart-Gebhart, Martine
Published in Nature communications (02.11.2023)
Published in Nature communications (02.11.2023)
Get full text
Journal Article
ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast
Agostinetto, Elisa, Nader-Marta, Guilherme, Paesmans, Marianne, Ameye, Lieveke, Veys, Isabelle, Buisseret, Laurence, Neven, Patrick, Taylor, Donatienne, Fontaine, Christel, Duhoux, Francois P, Canon, Jean-Luc, Denys, Hannelore, Coussy, Florence, Chakiba, Camille, Ribeiro, Joana Mourato, Piccart, Martine, Desmedt, Christine, Ignatiadis, Michail, Aftimos, Philippe
Published in Future oncology (London, England) (01.07.2022)
Published in Future oncology (London, England) (01.07.2022)
Get full text
Journal Article
Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial
Buisseret, Laurence, Loirat, Delphine, Aftimos, Philippe, Maurer, Christian, Punie, Kevin, Debien, Véronique, Kristanto, Paulus, Eiger, Daniel, Goncalves, Anthony, Ghiringhelli, François, Taylor, Donatienne, Clatot, Florent, Van den Mooter, Tom, Ferrero, Jean-Marc, Bonnefoi, Hervé, Canon, Jean-Luc, Duhoux, Francois P., Mansi, Laura, Poncin, Renaud, Barthélémy, Philippe, Isambert, Nicolas, Denis, Zoë, Catteau, Xavier, Salgado, Roberto, Agostinetto, Elisa, de Azambuja, Evandro, Rothé, Françoise, Craciun, Ligia, Venet, David, Romano, Emanuela, Stagg, John, Paesmans, Marianne, Larsimont, Denis, Sotiriou, Christos, Ignatiadis, Michail, Piccart-Gebhart, Martine
Published in Nature communications (12.12.2023)
Published in Nature communications (12.12.2023)
Get full text
Journal Article
Machine Learning Algorithm to Estimate Distant Breast Cancer Recurrence at the Population Level with Administrative Data
Izci, Hava, Macq, Gilles, Tambuyzer, Tim, De Schutter, Harlinde, Wildiers, Hans, Duhoux, Francois P, de Azambuja, Evandro, Taylor, Donatienne, Staelens, Gracienne, Orye, Guy, Hlavata, Zuzana, Hellemans, Helga, De Rop, Carine, Neven, Patrick, Verdoodt, Freija
Published in Clinical epidemiology (01.01.2023)
Published in Clinical epidemiology (01.01.2023)
Get full text
Journal Article
Abstract P2-01-04: Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab
Debien, Veronique, Agostinetto, Elisa, Sirico, Marianna, Jacobs, Flavia, Molinelli, Chiara, Moreau, Michel, Paesmans, Marianne, De Giorgi, Ugo, Santoro, Armando, Taylor, Donatienne, Duhoux, François P., Botticelli, Andrea, Barchiesi, Giacomo, Lambertini, Matteo, de Azambuja, Evandro, Piccart, Martine
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Pharmacokinetic Interaction Between the MEK1/MEK2 Inhibitor Trametinib and Oral Contraceptives Containing Norethindrone and Ethinyl Estradiol in Female Patients With Solid Tumors
Arkenau, Hendrik‐Tobias, Taylor, Donatienne, Xu, Xiaoying, Chitnis, Shripad, Llacer‐Perez, Casilda, Moore, Kathleen, Nidamarthy, Prasanna Kumar, Ilankumaran, Palanichamy, De Vos‐Geelen, Judith
Published in Clinical pharmacology in drug development (01.05.2022)
Published in Clinical pharmacology in drug development (01.05.2022)
Get full text
Journal Article
Abstract GS3-01: GS3-01 EMERALD phase 3 trial of elacestrant versus standard of care endocrine therapy in patients with ER+/HER2- metastatic breast cancer: Updated results by duration of prior CDK4/6i in metastatic setting
Bardia, Aditya, Bidard, Francois-Clement, Neven, Patrick, Streich, Guillermo, Montero, Alberto J., Forget, Frederic, Mouret-Reynier, Marie-Ange, Sohn, Joo Hyuk, Taylor, Donatienne, Harnden, Kathleen K., Khong, Hung, Kocsis, Judit, Dalenc, Florence, Dillon, Patrick, Babu, Sunil, Waters, Simon, Deleu, Ines, García-Sáenz, Jose Angel, Bria, Emilio, Cazzaniga, Marina Elena, Aftimos, Philippe, Cortés, Javier, Tonini, Giulia, Sahmoud, Tarek, Habboubi, Nassir, Grzegorzewski, Krzysztof, Kaklamani, Virginia
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract PS17-04: Clinical and Genomic Features of ER-Positive/HER2-negative Metastatic Breast Cancer in AURORA Molecular Screening Initiative (BIG 14-01): Mechanisms of Endocrine Therapy Resistance and Implications for Adjuvant Approaches
Guerrero-Zotano, Angel, Benelli, Matteo, Irrthum, Alexandre, Cameron, David, Ferrando, Lorenzo, Romagnoli, Dario, Paoli, Marta, Llinas, Arnau, Dadiani, Maya, Fimereli, Danai, Oliveira, Mafalda, Caballero, Carmela, Crestani, Thayane, Agostinetto, Elisa, Martins-Branco, Diogo, Hilbers, Florentine, Gal-Yam, Einav, Balic, Marija, Cardoso, Fatima, Reis-Filho, Jorge, Sotiriou, Christos, Curigliano, Giuseppe, Linderholm, Barbro, de Azambuja, Evandro, Knox, Susan, Rotaru, Cristina, Ciruelos, Eva, Davidson, Nancy E, Viale, Giuseppe, Taylor, Donatienne, Canon, Jean-Luc, Calvo, Lourdes, Albanell, Joan, Colleoni, Marco, Duhem, Caroline, Harbeck, Nadia, Herremans, Catherine, Loibl, Sibylle, Marreaud, Sandrine, Scheepers, Elsemieke, Raimbault, Alice, Goulioti, Theodora, Vingiani, Andrea, Biagioni, Chiara, Vosberg, Sebastian, Zoppoli, Gabriele, Seoane, Jose, Venet, David, Aftimos, Philippe, Piccart, Martine
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article